KDIGO is pleased to announce the publication of the 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD).
Read the news release: https://t.co/kXzi5xxCvK
Download the guideline: https://t.co/wA8RRI90j9
Read the guideline in Kidney International: https://t.co/VHIZL34ls8
The KDIGO 2024 CKD Guideline was co-chaired by @adeeralevin and @KidneysRU. The Executive Summary will be published in the April 2024 issue of @Kidney_Int.
“We are thrilled to publish this eagerly anticipated update, which comes during a transformative period in nephrology, offering new hope for people living with kidney disease," said Dr. Levin. “Recent advancements in GFR evaluation, risk prediction, and the arrival of novel treatments are poised to enhance CKD prognosis and management. We also hope the guideline’s emphasis on multidisciplinary teamwork, patient engagement, and a holistic, evidence-based approach to care will help catalyze positive change, resulting in more coordinated CKD care management worldwide. By integrating the latest evidence and expert consensus, we aim to empower healthcare professionals, and patients with actionable recommendations to optimize patient outcomes and enhance quality of life.”
“As Co-Chairs, we would like to recognize the outstanding efforts of the Guideline Work Group and extend our thanks to the Evidence Review Team from Johns Hopkins, without whom this guideline would not have been possible," said Dr. Stevens. "The Work Group was diverse, multinational, highly experienced, and exceptionally committed, and we are grateful for their contributions to both this guideline and to global nephrology.”
🦴🦴 Steroid induced Osteoporosis
🛎️Doses as low as 2.5 mg daily for 3-6 months can lead to fractures
✅FRAX-Fracture risk assessment tool -Calculates 10 year probability of fracture
🙏For Adults > 40 on steroids > 6 months-FRAX score should be done 👍
https://t.co/oE9PpgLqCm
Renal 🫘histopathology 🔬in ANCA vasculitis..
A. Necrotizing extracapillary proliferation/ crescents 🌙
B. Periglomerular granulomas🫘✨
C. Interstitial granulomas and tubulitis⭐️💥
D. Segmental fibrinoid necrosis in interlobular arteries 🩸💥